Second, we found that lung or ovarian cancer cells with inactivated SMARCA4 not only were refractory to the growth suppression triggered by SAHA, but also aberrantly accumulated H3K27me3 following the administration of this inhibitor. Here, SMARCA4 is linked to ovarian carcinoma.